1 Min Read
Nov 6 (Reuters) - Neovasc Inc
* Neovasc receives FDA approval to initiate pivotal reducer trial
* Neovasc Inc - Co is currently evaluating start up timelines and funding options for Cosira-II trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.